Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
- PMID: 384241
- DOI: 10.1056/NEJM197909273011303
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
Abstract
One hundred and fifty patients with advanced cancer participated in a controlled double-blind study to evaluate the effects of high-dose vitamin C on symptoms and survival. Patients were divided randomly into a group that received vitamin C (10 g per day) and one that received a comparably flavored lactose placebo. Sixty evaluable patients received vitamin C and 63 received a placebo. Both groups were similar in age, sex, site of primary tumor, performance score, tumor grade and previous chemotherapy. The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight. The median survival for all patients was about seven weeks, and the survival curves essentially overlapped. In this selected group of patients, we were unable to show a therapeutic benefit of high-dose vitamin C treatment.
Similar articles
-
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.N Engl J Med. 1985 Jan 17;312(3):137-41. doi: 10.1056/NEJM198501173120301. N Engl J Med. 1985. PMID: 3880867 Clinical Trial.
-
Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.Eur J Obstet Gynecol Reprod Biol. 2004 Nov 10;117(1):70-5. doi: 10.1016/j.ejogrb.2004.02.032. Eur J Obstet Gynecol Reprod Biol. 2004. PMID: 15474248 Clinical Trial.
-
Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.N Engl J Med. 1979 Apr 5;300(14):756-9. doi: 10.1056/NEJM197904053001403. N Engl J Med. 1979. PMID: 370586 Clinical Trial.
-
High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.Anticancer Res. 2009 Mar;29(3):809-15. Anticancer Res. 2009. PMID: 19414313 Review.
-
Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?P R Health Sci J. 2010 Sep;29(3):215-7. P R Health Sci J. 2010. PMID: 20799507 Review.
Cited by
-
Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy.J Pers Med. 2024 Jun 26;14(7):685. doi: 10.3390/jpm14070685. J Pers Med. 2024. PMID: 39063939 Free PMC article. Review.
-
Nuclear and Cytoplasmic Functions of Vitamin C.Chem Res Toxicol. 2020 Oct 19;33(10):2515-2526. doi: 10.1021/acs.chemrestox.0c00348. Epub 2020 Oct 1. Chem Res Toxicol. 2020. PMID: 33001635 Free PMC article. Review.
-
Proposal of next-generation medical care "Mega-hydrogen Therapy".Med Gas Res. 2020 Jul-Sep;10(3):140-141. doi: 10.4103/2045-9912.296045. Med Gas Res. 2020. PMID: 33004714 Free PMC article. Review. No abstract available.
-
Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid.J Orthomol Med. 2010;25(1):29-38. J Orthomol Med. 2010. PMID: 23565030 Free PMC article.
-
Potential health risks of complementary alternative medicines in cancer patients.Br J Cancer. 2004 Jan 26;90(2):408-13. doi: 10.1038/sj.bjc.6601560. Br J Cancer. 2004. PMID: 14735185 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources